[2P] Poster Presentation 2

[2P-875] Bortezomib Restores Venetoclax Sensitivity in AML with Intrinsic and Acquired Resistance

○Chengxi Li¹, Toshio Kitamura^2,3, Susumu Goyama⁴, Yutaka Enomoto³ (1. Department of Internal Medicine, Graduate School of Medicine, The University of Tokyo, 2. Institute of Biomedical Research Innovation, Foundation for Biomedical Research Innova- tion at Kobe, 3. Division of Molecular Oncology, Graduate School of Frontier Sciences, The University of Tokyo, 4. Molecular Pharmacology of malignant Diseases, Graduate School of Pharma- ceutical Sciences, The University of Tokyo)